一、 英文文献

1.             Chen W, Wang JB, Abnet CC, Dawsey SM, Fan JH, Yin LY, Yin J, Taylor PR, Qiao YL, Freedman ND: Association between C-Reactive Protein, Incident Liver Cancer, and Chronic Liver Disease Mortality in the Linxian Nutrition Intervention Trials: A Nested Case-Control Study. Cancer Epidemiology Biomarkers & Prevention 2015, 24(2):386-392. doi: 10.1158/1055-9965.Epi-14-1038.

2.             Jeronimo J, Bansil P, Valdez M, Kang LN, Zhao FH, Qiao YL, Chen W, Zhang X, Paul P, Bai P et al: The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer. Journal of Lower Genital Tract Disease 2015, 19(3):220-223. doi: 10.1097/lgt.0000000000000088.

3.             Liao GD, Kang LN, Chen W, Zhang X, Liu XY, Zhao FH, Stoler MH, Mills A, Xi MR, Qiao YL et al: p16 Immunohistochemistry Interpretation by Nonpathologists as an Accurate Method for Diagnosing Cervical Precancer and Cancer. Journal of Lower Genital Tract Disease 2015, 19(3):207-211. doi: 10.1097/lgt.0000000000000080.

4.             Lin CQ, Cui JF, Zhang X, Pan QJ, Chen W, Qiao YL: Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China. Acta Cytologica 2015, 59(5):405-411. doi: 10.1159/000441290.

5.             Song Y, Zhao YQ, Zhang X, Liu XY, Li L, Pan QJ, Shen GH, Zhao FH, Chen F, Chen W et al: Random biopsy in colposcopy-negative quadrant is not effective in women with positive colposcopy in practice. Cancer Epidemiology 2015, 39(2):237-241. doi: 10.1016/j.canep.2015.01.008.

6.             Wang SM, Hu SY, Chen W, Chen F, Zhao FH, He W, Ma XM, Zhang YQ, Wang J, Sivasubramaniam P et al: Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening. Bmc Cancer 2015, 15. doi: 10.1186/s12885-015-1882-9.

7.             Chen W, Molijn A, Wu EQ, Zhang X, Jenkins D, Yu XH, Quint W, Schmidt JE, Li J, Pirog E et al: The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China. International Journal of Cancer 2016, 139(12):2687-2697. doi: 10.1002/ijc.30401.

8.             Molijn A, Jenkins D, Chen W, Zhang X, Pirog E, Enqi W, Liu B, Schmidt J, Cui JF, Qiao YL et al: The complex relationship between human papillomavirus and cervical adenocarcinoma. International Journal of Cancer 2016, 138(2):409-416. doi: 10.1002/ijc.29722.

9.             Qin Y, Zhang HY, Marlowe N, Fei MD, Yu J, Lei XQ, Yu LL, Zhang J, Cao D, Ma L et al: Evaluation of human papillomavirus detection by Abbott m2000 system on samples collected by FTA Elute (TM) Card in a Chinese HIV-1 positive population. Journal of Clinical Virology 2016, 85:80-85. doi: 10.1016/j.jcv.2016.11.002.

10.          Valdez M, Jeronimo J, Bansil P, Qiao YL, Zhao FH, Chen W, Zhang X, Kang LN, Paul P, Bai P et al: Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china. International Journal of Cancer 2016, 138(6):1453-1461. doi: 10.1002/ijc.29877.

11.          Yu LL, Guo HQ, Lei XQ, Qin Y, Wu ZN, Kang LN, Zhang X, Qiao YL, Chen W: p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China. Oncotarget 2016, 7(40):64810-64819. doi: 10.18632/oncotarget.11705.

12.          Yu LL, Kang LN, Zhao FH, Lei XQ, Qin Y, Wu ZN, Wang H, Chen W, Qiao YL: Elevated Expression of Human Papillomavirus-16/18 E6 Oncoprotein Associates with Persistence of Viral Infection: A 3-Year Prospective Study in China. Cancer Epidemiology Biomarkers & Prevention 2016, 25(7):1167-1174. doi: 10.1158/1055-9965.Epi-15-1057.

13.          Dong L, Lin CQ, Li L, Wang M, Cui JF, Feng RM, Liu B, Wu ZN, Lian J, Liao GD et al: An evaluation of clinical performance of FTA cards for HPV 16/18 detection using cobas 4800 HPV Test compared to dry swab and liquid medium. Journal of Clinical Virology 2017, 94:67-71. doi: 10.1016/j.jcv.2017.06.008.

14.          Hu SY, Zhang WH, Li SM, Li N, Huang MN, Pan QJ, Zhang X, Han Y, Zhao FH, Chen W et al: Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy. Medicine 2017, 96(17). doi: 10.1097/md.0000000000006689.

15.          Lin CQ, Zeng X, Cui JF, Liao GD, Wu ZN, Gao QQ, Zhang X, Yu XZ, Chen W, Xi MR et al: Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test (vol 55, pg 568, 2017). Journal of Clinical Microbiology 2017, 55(6):1972-1972. doi: 10.1128/jcm.00598-17.

16.          Lin CQ, Zeng X, Cui JF, Liao GD, Wu ZN, Gao QQ, Zhang X, Yu XZ, Chen W, Xi MR et al: Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test. Journal of Clinical Microbiology 2017, 55(2):568-573. doi: 10.1128/jcm.02025-16.

17.          Song Y, Zhao YQ, Li L, Pan QJ, Li N, Zhao FH, Chen W, Zhang X, Qiao YL: A retrospective analysis of the utility of endocervical curettage in screening population. Oncotarget 2017, 8(30):50141-50147. doi: 10.18632/oncotarget.15658.

18.          Wang HR, Li YC, Guo HQ, Yu LL, Wu ZN, Yin J, Liao GD, Qu YM, Jiang Y, Wang D et al: A cocktail of p16(INK4a) and Ki-67, p16(INK4a) and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening. Oncotarget 2017, 8(48):83890-83899. doi: 10.18632/oncotarget.19870.

19.          Wu ZN, Qin Y, Yu LL, Lin CQ, Wang H, Cui JF, Liu B, Liao YQ, Warren D, Zhang X et al: Association Between Human Papillomavirus (HPV) 16, HPV18, and Other HR-HPV Viral Load and the Histological Classification of Cervical Lesions: Results From a Large-Scale Cross-Sectional Study. Journal of Medical Virology 2017, 89(3):535-541. doi: 10.1002/jmv.24645.

20.          Chen W, Sun HK, Molijn A, Zeng L, Kang LN, Jenkins D, Zhang SK, Cui JF, Wu ZN, Pirog E et al: The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China. Journal of Lower Genital Tract Disease 2018, 22(4):355-361. doi: 10.1097/lgt.0000000000000408.

21.          Dong L, Yin J, Zhao J, Ma SR, Wang HR, Wang M, Chen W, Wei WQ: Microbial Similarity and Preference for Specific Sites in Healthy Oral Cavity and Esophagus. Frontiers in Microbiology 2018, 9. doi: 10.3389/fmicb.2018.01603.

22.          Wu ZN, Yu LL, Lei XQ, Qin Y, Zhang X, Chen W, Qiao YL: The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer. Journal of Clinical Virology 2018, 108:6-11. doi: 10.1016/j.jcv.2018.08.008.

23.          Yu LL, Jiang MY, Qu PP, Wu ZN, Sun PS, Xi MR, Qin Y, Liu X, Liao GD, Lei XQ et al: Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage. International Journal of Cancer 2018, 143(4):813-822. doi: 10.1002/ijc.31368.

24.          Chen W, Zhao Y, Xie X, Liu JH, Li JR, Zhao C, Wang SM, Liao XY, Shou Q, Zheng MH et al: Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up. Vaccine 2019, 37(6):889-897. doi: 10.1016/j.vaccine.2018.12.030.

25.          Dong L, Li TY, Li L, Wang MZ, Wu ZN, Cui JF, Liu B, Zhang X, Qiao YL, Chen W: Clustering patterns of type-type combination in multiple genotypes infections of human papillomavirus in cervical adenocarcinoma. Journal of Medical Virology 2019, 91(11):2001-2008. doi: 10.1002/jmv.25553.

26.          Liu AQ, Vogtmann E, Shao DT, Abnet CC, Dou HY, Qin Y, Su Z, Wei WQ, Chen W: A Comparison of Biopsy and Mucosal Swab Specimens for Examining the Microbiota of Upper Gastrointestinal Carcinoma. Cancer Epidemiology Biomarkers & Prevention 2019, 28(12):2030-2037. doi: 10.1158/1055-9965.Epi-18-1210.

27.          Pirog EC, Park KJ, Kiyokawa T, Zhang X, Chen W, Jenkins D, Quint W: Gastric-type Adenocarcinoma of the Cervix: Tumor With Wide Range of Histologic Appearances. Advances in Anatomic Pathology 2019, 26(1):1-12. doi: 10.1097/pap.0000000000000216.

28.          Wei LH, Xie X, Liu JH, Zhao Y, Chen W, Zhao C, Wang SM, Liao XY, Shou Q, Qiu YZ et al: Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up. Vaccine 2019, 37(27):3617-3624. doi: 10.1016/j.vaccine.2018.08.009.

29.          Wu ZN, Li TY, Jiang MY, Yu LL, Zhao J, Wang HR, Zhang X, Chen W, Qiao YL: Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes. Cancer Prevention Research 2019, 12(2):95-101. doi: 10.1158/1940-6207.Capr-18-0343.

30.          Xue P, Gao LL, Yin J, Han LL, Zhao J, Li L, Seery S, Han XY, Li TY, Jiang Y et al: A direct comparison of four high-risk human papillomavirus tests versus the cobas test: Detecting CIN2 in low-resource settings. Journal of Medical Virology 2019, 91(7):1342-1350. doi: 10.1002/jmv.25451.

31.          Zhang SK, Jia MM, Zhao DM, Wu ZN, Guo Z, Liu YL, Guo PP, Chen Q, Cao XQ, Liu SZ et al: Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China. Cancer Epidemiology 2019, 59:123-128. doi: 10.1016/j.canep.2018.12.013.

32.          Jiang MY, Wu ZN, Li TY, Yu LL, Zhang SK, Zhang X, Qu PP, Sun PS, Xi MR, Liu X et al: Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women. Cancer Prevention Research 2020, 13(2):163-171. doi: 10.1158/1940-6207.Capr-19-0144.

33.          Li TY, Wu ZN, Jiang MY, Zhao YQ, Yu LL, Qin Y, Liu B, Cui JF, Li L, Pan QJ et al: Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women. Gynecologic Oncology 2020, 157(1):202-208. doi: 10.1016/j.ygyno.2020.01.011.

34.          Liao GD, Jiang XY, She B, Tang HJ, Wang ZY, Zhou HR, Ma Y, Xu WD, Xu HX, Chen W et al: Multi-Infection Patterns and Co-infection Preference of 27 Human Papillomavirus Types Among 137,943 Gynecological Outpatients Across China. Frontiers in Oncology 2020, 10. doi: 10.3389/fonc.2020.00449.

35.          Zhang DY, Chen W, Zhang HY, Lv SQ, Lu XN, Tao YP, Zhang M, Liu JF, Yang M, Qiao YL et al: Cervical neoplastic lesions in relation to CD4 T-lymphocyte counts and antiretroviral therapy among women with clinical stage 1 HIV in Yunnan, China. Kaohsiung Journal of Medical Sciences 2020, 36(6):450-459. doi: 10.1002/kjm2.12175.

二、中文文献

 [1]    于露露, 陈汶. 子宫颈癌筛查技术新进展 中华妇产科杂志 [J]. 2015, 50(04): 312-5.

[2]    张永侠, 张彬, 周慧芳等. 人乳头状瘤病毒相关扁桃体癌患者临床特征及p16和p53蛋白表达情况 中华耳鼻咽喉头颈外科杂志 [J]. 2015, 50(02): 131-7.

[3]    赵宇倩, 宋艳, 赵方辉等. 阴道镜下四象限活检在宫颈癌前病变筛查中的价值 中华肿瘤杂志 [J]. 2015, 37(11): 875-9.

[4]    赵宇倩, 赵方辉, 胡尚英等. 中国女性人群宫颈人乳头瘤病毒感染及型别分布的多中心横断面研究 中华流行病学杂志 [J]. 2015, 36(12): 1351-6.

[5]    雷晓琴, 陈汶, 于露露等. 河南新密农村地区妇女生活方式、膳食因素与高危型HPV持续感染的关系研究  卫生研究 [J]. 2016, 45(01): 45-50.

[6]    刘彬, 吴泽妮, 刘潇阳等. 人乳头瘤病毒与子宫颈腺癌病因关系研究 中华肿瘤杂志 [J]. 2016, 38(04): 277-82.

[7]    刘文羽, 卫飞雪, 唐杰等. 江苏省阜宁地区自然人群中18～45岁女性人乳头瘤病毒16、18型中和抗体及DNA的流行率 中华流行病学杂志 [J]. 2016, 37(03): 406-9.

[8]    吴泽妮, 陈汶. 人乳头瘤病毒自然史与空间分布特征对宫颈癌筛查技术的影响  中华肿瘤杂志 [J]. 2016, 38(04): 241-5.

[9]    吴泽妮, 秦宇, 李婷媛等. 透景HPV检测试剂在高危HPV DNA检测及宫颈上皮内瘤变筛查中的应用 临床检验杂志 [J]. 2016, 34(02): 90-4.

[10]  冯瑞梅, 陈汶, 乔友林. 高危型人乳头瘤病毒核酸体外检测试剂盒临床功能验证的中美指导原则解读  中华肿瘤杂志 [J]. 2017, 39(07): 553-7.

[11]  王海瑞, 廖光东, 陈汶等. p16/Ki-67免疫细胞化学双染在宫颈癌筛查中的应用价值 中华肿瘤杂志 [J]. 2017, 39(08): 636-40.

[12]  王海瑞, 廖光东, 江宇等. p16/mcm2双染在宫颈上皮内瘤变的诊断价值及其与高危型HPV感染的关系  中华流行病学杂志 [J]. 2017, 38(09): 1241-5.

[13]  吴昕, 赵骏, 崔雪莲等. 广西壮族自治区柳州市18～45岁社区女性人乳头瘤病毒感染及型别分布的横断面调查  中华流行病学杂志 [J]. 2017, 38(04): 467-71.

[14]  张永侠, 刘明波, 黄辉等. 124例舌根鳞状细胞癌临床总结及预后分析 临床耳鼻咽喉头颈外科杂志 [J]. 2017, 31(24): 1867-72.

[15]  赵骏, 吴昕, 崔雪莲等. 广西柳州18～45岁女性人乳头瘤病毒16/18型中和抗体流行率及其与宫颈病变相关性的研究  病毒学报 [J]. 2017, 33(03): 354-60.

[16]  陈汶. 接种疫苗与筛查并重  中国科学报 [N]. 2018-2018-05-18.

[17]  姜明月, 冯瑞梅, 王林等. 液基细胞学联合人乳头状瘤病毒核酸检测对宫颈癌筛查的效果评价  中华肿瘤杂志 [J]. 2018, 40(10): 750-6.

[18]  李菊晓, 董丽, 李莉等. 高危型人乳头状瘤病毒感染人群分流方法的研究进展  中华肿瘤杂志 [J]. 2018, 40(09): 641-6.

[19]  李莉, 陈汶, 杨欢等. HPV检测技术在宫颈癌中的研究进展  癌症进展 [J]. 2018, 16(03): 278-81.

[20]  李莉, 王林, 李菊晓等. 宫颈细胞内p16/Ki67表达与宫颈癌及癌前病变的关系及其用于HPV阳性人群分流的诊断价值  中国肿瘤 [J]. 2018, 27(04): 311-5.

[21]  李莉, 王林, 李志芳等. Aptima HPV E6/E7mRNA技术检出宫颈癌及癌前病变的临床效果研究    中国妇产科临床杂志 [J]. 2018, 19(04): 341-4.

[22]  李婷媛, 吴泽妮, 姜明月等. 不同感染状态下高危型人乳头状瘤病毒载量与子宫颈病变发生的关系  中华肿瘤杂志 [J]. 2018, 40(06): 475-80.

[23]  刘植华, 林威, 王月云等. 高危型人乳头状瘤病毒风险分层在深圳地区人乳头状瘤病毒初筛阳性人群分流中的应用  中华肿瘤杂志 [J]. 2018, 40(10): 757-63.

[24]  王林, 姜明月, 曹雪芳等. 恒温扩增HPV检测技术应用于子宫颈癌筛查的效果评价研究    病毒学报 [J]. 2018, 34(04): 498-504.

[25]  王林, 姜明月, 秦宇等. 人乳头状瘤病毒DNA恒温扩增技术在宫颈癌筛查中的应用价值     中华肿瘤杂志 [J]. 2018, 40(04): 313-8.

[26]  王月云, 林威, 吴波等. 2014—2016年深圳市子宫颈癌筛查中HPV阳性者HPV高危亚型分布及相关因素  中华预防医学杂志 [J]. 2018, 52(05): 480-5.

[27]  吴泽妮, 苏征, 陈汶等. 人乳头状瘤病毒检测在28 923例不能明确意义的不典型鳞状细胞患者中的应用:中国104项研究汇总分析 中华病理学杂志 [J]. 2018, 47(04): 269-73.

[28]  赵静, 陈汶, 刘植华等. 常见阴道微生态异常与高危型HPV感染及子宫颈癌相关性研究进展     中国热带医学 [J]. 2018, 18(11): 1099-102.

[29]  赵静, 李芹, 曹雪芳等. 云南新平县女性阴道微生态异常与HR-HPV的相关性研究 中国热带医学 [J]. 2018, 18(12): 1222-5.

[30]  梁青壮, 韦伟, 陈汶等. 鼻腔鼻窦内翻性乳头状瘤恶变鳞状细胞癌中HPV的分布及预后分析     中国耳鼻咽喉颅底外科杂志 [J]. 2019, 25(02): 172-6.

[31]  柳安琪 and 陈汶. 食管微生物与食管相关疾病研究进展 中华肿瘤杂志 [J]. 2019, 08): 561-4.

[32]  柳安琪, 邵丹彤, 苏征等. 贲门癌患者口腔菌群的分布特征 基础医学与临床 [J]. 2019, 39(05): 710-3.

[33]  沈洁, 韩历丽, 张月等. 高危型人乳头瘤病毒检测用于子宫颈癌筛查的评估分析 中国妇产科临床杂志 [J]. 2019, 20(02): 146-8.

[34]  薛鹏, 沈洁, 李莉等. HPV E6/E7 mRNA和HPV DNA检测技术在宫颈上皮内瘤变中的诊断价值分析  癌症进展 [J]. 2019, 17(10): 1160-3 77.

[35]  张永侠, 刘明波, 黄辉等. 第七版与第八版美国癌症联合会TNM分期对口咽癌预后生存的分析比较 临床耳鼻咽喉头颈外科杂志 [J]. 2019, 33(07): 586-90.

[36]  魏丽惠, 谢幸, 刘继红等. 四价人乳头瘤病毒疫苗预防中国大陆女性HPV持续感染及下生殖道相关疾病的保护效力:一项随访78个月的随机对照研究 中国妇产科临床杂志 [J]. 2020, 21(02): 158-62.

[37]  薛鹏, 沈洁, 韩历丽等. 国内人乳头瘤病毒检测技术在不同实验室间的重复性评价研究    癌症进展 [J]. 2020, 18(05): 456-8 74.

[38]  张韶凯, 罗喜平, 李志芳等. 人乳头瘤病毒分型检测在宫颈癌前病变和宫颈癌筛查中的应用价值 中华肿瘤杂志 [J]. 2020, 03): 252-3-4-5-6.

[39]  周静, 玛依努尔·尼亚孜, 周琦等. 我国西部地区宫颈癌患者HPV感染现状及影响因素分析     中国妇产科临床杂志 [J]. 2020, 21(01): 13-6.